Reshape Biotech Revenue and Competitors

Copenhagen, Denmark

Location

#5666

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Reshape Biotech's estimated annual revenue is currently $5.7M per year.(i)
  • Reshape Biotech's estimated revenue per employee is $155,000

Employee Data

  • Reshape Biotech has 37 Employees.(i)
  • Reshape Biotech grew their employee count by 68% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7910M27846%$204.3MN/A
#2
$42.8M2768%N/AN/A
#3
$3.4M1097-1%$85.7MN/A
#4
$13.2M12-77%$263.3MN/A
#5
$22.9M14817%N/AN/A
#6
$3.6M2310%N/AN/A
#7
$28.5M18437%N/AN/A
#8
$1.6M10-17%N/AN/A
#9
$10.1M6535%N/AN/A
#10
$9.1M5959%N/AN/A
Add Company

What Is Reshape Biotech?

Reshape Biotech is building the next generation of lab automation robots. Our customers are biotech companies tackling the world’s biggest problems - be it alternative protein development or sustainable agriculture. Reshape Biotech is the scaling factor for these companies, as we let researchers collaborate globally on experiments and increase their throughput >500x.\n\nThe team is highly multi-disciplinary, employing everything from PhD’s in biology to hardware and software engineers. We work closely together, and you will be exposed to a truly vertical team.\n\nWe’re a fast growing startup with an incredibly ambitious team, dead-set on reinventing a 100 year old industry and becoming the standard infrastructure that the world of biotech relies on. Our customers already include global leaders in food, agriculture and biologicals. \n\nWe’re backed by top tier investors from Y Combinator, CEOs from the industry and some of the biggest names you can find. At Reshape Biotech, you have the potential to influence how biotech research is done in the next 100 years.

keywords:N/A

N/A

Total Funding

37

Number of Employees

$5.7M

Revenue (est)

68%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.2M3761%N/A
#2
$6.9M38-28%N/A
#3
$5.3M3846%N/A
#4
$15M389%N/A
#5
N/A3939%N/A